Mitochondrial DNA depletion syndrome, encephalomyopathic form

Mitochondrial DNA depletion syndrome, encephalomyopathic form (also known as MDDS, encephalomyopathic form) is a group of severe genetic disorders characterized by a significant reduction in mitochondrial DNA (mtDNA) copy number in affected tissues, primarily the brain and skeletal muscle. This leads to impaired mitochondrial energy production, which is critical for the function of high-energy-demand organs. The condition belongs to the broader category of mitochondrial DNA depletion syndromes and can be caused by mutations in several nuclear genes involved in mtDNA maintenance and nucleotide metabolism, including RRM2B, SUCLA2, SUCLG1, and TK2, among others. The inheritance pattern is autosomal recessive. Clinical features typically present in infancy or early childhood and include progressive encephalopathy (brain dysfunction), myopathy (muscle weakness), hypotonia (reduced muscle tone), psychomotor regression or developmental delay, seizures, and failure to thrive. Lactic acidosis is a common metabolic finding. Depending on the specific genetic cause, additional features may include sensorineural hearing loss, movement abnormalities such as dystonia, feeding difficulties, and respiratory insufficiency. Some subtypes may also involve elevated methylmalonic acid levels (particularly SUCLA2- and SUCLG1-related forms). The disease course is generally progressive and often severe, with many affected children experiencing significant neurological decline. Currently, there is no curative treatment for mitochondrial DNA depletion syndrome, encephalomyopathic form. Management is primarily supportive and symptomatic, including nutritional support, physical therapy, seizure management with anticonvulsant medications, and respiratory support as needed. Certain mitochondria-toxic medications (such as valproic acid) should be avoided. Research into nucleoside supplementation therapies and gene therapy is ongoing but remains largely experimental. Genetic counseling is recommended for affected families.

Common questions about Mitochondrial DNA depletion syndrome, encephalomyopathic form